1. Home
  2. NRXP vs STEC Comparison

NRXP vs STEC Comparison

Compare NRXP & STEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • STEC
  • Stock Information
  • Founded
  • NRXP 2015
  • STEC 2006
  • Country
  • NRXP United States
  • STEC Hong Kong
  • Employees
  • NRXP N/A
  • STEC N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • STEC
  • Sector
  • NRXP Health Care
  • STEC
  • Exchange
  • NRXP Nasdaq
  • STEC NYSE
  • Market Cap
  • NRXP 58.5M
  • STEC 63.8M
  • IPO Year
  • NRXP N/A
  • STEC 2021
  • Fundamental
  • Price
  • NRXP $2.81
  • STEC $0.74
  • Analyst Decision
  • NRXP Strong Buy
  • STEC
  • Analyst Count
  • NRXP 4
  • STEC 0
  • Target Price
  • NRXP $28.50
  • STEC N/A
  • AVG Volume (30 Days)
  • NRXP 134.9K
  • STEC 10.9K
  • Earning Date
  • NRXP 08-13-2025
  • STEC 08-05-2025
  • Dividend Yield
  • NRXP N/A
  • STEC N/A
  • EPS Growth
  • NRXP N/A
  • STEC N/A
  • EPS
  • NRXP N/A
  • STEC N/A
  • Revenue
  • NRXP N/A
  • STEC $10,672,000.00
  • Revenue This Year
  • NRXP N/A
  • STEC $9,392.20
  • Revenue Next Year
  • NRXP $230.95
  • STEC N/A
  • P/E Ratio
  • NRXP N/A
  • STEC N/A
  • Revenue Growth
  • NRXP N/A
  • STEC N/A
  • 52 Week Low
  • NRXP $1.10
  • STEC $0.20
  • 52 Week High
  • NRXP $6.01
  • STEC $3.25
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 35.57
  • STEC 40.44
  • Support Level
  • NRXP $2.89
  • STEC $0.70
  • Resistance Level
  • NRXP $3.15
  • STEC $0.80
  • Average True Range (ATR)
  • NRXP 0.14
  • STEC 0.08
  • MACD
  • NRXP -0.04
  • STEC 0.00
  • Stochastic Oscillator
  • NRXP 7.27
  • STEC 38.55

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About STEC SANTECH HOLDINGS LIMITED

Santech Holdings Ltd is a technology company focusing on exploring various opportunities in consumer technology, consumer healthcare and enterprise technology. It has two revenue segments Wealth management service and Asset management service. Key revenue is generated from Wealth management service.

Share on Social Networks: